AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Author's Avatar
Dec 20, 2022

AtriCure%2C+Inc. (Nasdaq%3A+ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.